SEC Form 4 · accession 0001209191-16-110290
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meghan Fitzgerald
Director
Period of report
Mar 22, 2016
Accepted (ET)
Mar 23, 2016 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (right to buy)F1 | $13.68 | Mar 22, 2016 | A | 25,000 | A | — | Mar 21, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The shares underlying this option vest in equal quarterly installments over a three-year period measured from the date of grant, subject to the Reporting Person's continued service as a director, and will become exercisable in full upon a change in control of the Issuer.